MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

End-of-life care management in Parkinson’s disease: a nationwide survey of French healthcare practitioners’ experiences and perceptions

A. Lagarde, A. Camm Chapel, T. Cognard, M. Auffret (Paris, France)

Meeting: 2025 International Congress

Keywords: Aging, Parkinson’s

Category: Parkinson's Disease (Other)

Objective: To describe the personal experiences and perceptions of healthcare practitioners (HCP) involved in the terminal management of people diagnosed with Parkinson’s disease (PD)

Background: Palliative care is receiving a growing interest in PD worldwide. In France, the APO-PALLIA project, started in 2018, highlighted several practice gaps. However, the perceptions, knowledge or experience of HCP involved in the terminal management of people diagnosed with Parkinson’s disease (PD) at a national level was not investigated.

Method: Online questionnaire, accessible from September 19, 2024 to October 31, 2024. Among the 953 responders, 789 HCP (82% females, mean age 45 years old) had taken care of PD patients at a terminal stage, mostly in healthcare facilities (61% nursing homes, 19% teaching hospitals). 44% of responders were nurses, 27% were physicians (50% geriatricians, 34% palliative care specialists, 25% general practitioners and 6% neurologists).

Results: 45% of respondents felt that PD specificities are not considered in patient care, primarily due to a lack of knowledge (only 40% claimed to have a good understanding of the disease and its specific features). 46% considered that care coordination was unsatisfactory. Neurological follow-up was maintained (46%) but suboptimal, discontinued (37%) or irregular (45%).  83% of HCP surveyed said that PD treatments are generally maintained until the end. Patient adherence was highlighted as an issue (56%). The main reason for stopping treatment was unavailability of the oral route (86%). Advance directives for palliative and end-of-life care were discussed (60%), but nearly half of the HCP felt that it was too late. Knowledge, needs and complaints were different between HCP according to their methods of practice (inpatients, home-care services, nursing homes,..) suggesting that one-size-fits-all interventions are unlikely to be successful.

Conclusion: Targeted educational interventions are needed to improve quality of care. Efforts must be made at local, regional and national levels to improve coordination of care and palliative care approaches.

References: Acknowledgments : The authors thank all of the participants, as well as Viavoice for carrying out the analysis

To cite this abstract in AMA style:

A. Lagarde, A. Camm Chapel, T. Cognard, M. Auffret. End-of-life care management in Parkinson’s disease: a nationwide survey of French healthcare practitioners’ experiences and perceptions [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/end-of-life-care-management-in-parkinsons-disease-a-nationwide-survey-of-french-healthcare-practitioners-experiences-and-perceptions/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/end-of-life-care-management-in-parkinsons-disease-a-nationwide-survey-of-french-healthcare-practitioners-experiences-and-perceptions/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley